Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 1.014% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) N#Cc1c(C(F)(F)F)cc(-c2ccc(Cl)c(Cl)c2)nc1SCCN1CCOCC1
b) CCCc1ccccc1OCCNS(=O)(=O)c1cc2c(cc1C)OCC(=O)N2
Answer: b. CCCc1ccccc1OCCNS(=O)(=O)c1cc2c(cc1C)OCC(=O)N2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCc1ccccc1OCCNS(=O)(=O)c1cc2c(cc1C)OCC(=O)N2
CCCc1ccccc1OCCNS(=O)(=O)c1cc2c(cc1C)OCC(=O)N2
7-methyl-3-oxo-N-[2-(2-propylphenoxy)ethyl]-4H-1,4-benzoxazine-6-sulfonamide